Author | Nancy L. Lewis, MD | OncLive

Author | Nancy L. Lewis, MD

Articles

Dr. Nancy Lewis Discusses the Regorafenib CORRECT Trial

October 18, 2012

Video

Nancy L. Lewis, MD, from the Thomas Jefferson University Hospitals, discusses the phase III CORRECT trial that examined the multitargeted tyrosine kinase inhibitor regorafenib.

x